Mesothelioma Cancer Centers
Mayo Clinic Hospital
Doctors Affiliated with this Treatment Facility
The Mayo Clinic Hospital was founded in 1998 with the mission to provide the most quality healthcare to patients in Arizona and from around the world. It is part of a network of Mayo Clinic facilities throughout the country, noted for their advancements in treatment and cancer care. Each year, more than one million patients are treated at a Mayo Clinic facility for a variety of conditions, including mesothelioma. More than 100 mesothelioma patients choose a Mayo Clinic care center for their treatment each year.
Patients with mesothelioma living in Arizona can benefit from treatment at the Mayo Clinic Hospital or the Scottsdale campus just 14 miles away. Specialists at these centers have experience in diagnosing and treating the rare cancer, and many are also actively involved in research and clinical trials. Patients are often treated with a multimodal approach, meaning a combination of surgery, chemotherapy and/or radiation, while working with a team of oncologists that collaborate to develop the most effective, personalized plan for each individual. Since the hospital is heavily involved in research, patients may also have access to emerging treatments that could extend survival, like immunotherapy or gene therapy.
The Mayo Clinic Hospital and other affiliates also offer a variety of coping and supportive programs for patients and their families when facing a difficult time. The facility also helps patients connect with long-term lodging and travel, as well as helps with insurance and understanding the cost of treatment. The Mayo Clinic Hospital also offers an education center, where patients and their loved ones can talk to health specialists and better understand information about their individual diagnosis.
- Peritoneal mesothelioma
- Multimodal therapy
- Radiation oncology
- U.S. World & News Report Top Hospital in Arizona
Mesothelioma Clinical Trials at Mayo Clinic Hospital
The following clinical trials are in progress or actively recruiting participants at Mayo Clinic Hospital:
Ph 2/3 Study in Subjects With MPM w/Low ASS 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Conditions: Mesothelioma Last Updated: July 18, 2019 Status: Recruiting
Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma
Conditions: Mesothelin Positive; Pleural Malignant Mesothelioma Last Updated: July 17, 2019 Status: Recruiting
Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
Conditions: Biphasic Mesothelioma; Epithelioid Mesothelioma; Stage I Pleural Malignant Mesothelioma AJCC v7; Stage IA Pleural Malignant Mesothelioma AJCC v7; Stage IB Pleural Malignant Mesothelioma AJCC v7; Stage II Pleural Malignant Mesothelioma AJCC v7; Stage III Pleural Malignant Mesothelioma AJCC v7 Last Updated: July 4, 2019 Status: Recruiting